| Beverly Hills Concierge Doctor, Inc | |
|
9400 Brighton Way #410 Beverly Hills CA 90210-4714 | |
| (310) 683-0180 | |
| Not Available |
| Full Name | Beverly Hills Concierge Doctor, Inc |
|---|---|
| Speciality | Internal Medicine |
| Location | 9400 Brighton Way, Beverly Hills, California |
| Authorized Official Name and Position | Ehsan Ali (CEO) |
| Authorized Official Contact | 3106830180 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Beverly Hills Concierge Doctor, Inc 9400 Brighton Way #410 Beverly Hills CA 90210-4714 Ph: (310) 683-0180 | Beverly Hills Concierge Doctor, Inc 9400 Brighton Way #410 Beverly Hills CA 90210-4714 Ph: (310) 683-0180 |
| NPI Number | 1073916193 |
|---|---|
| Provider Enumeration Date | 10/03/2014 |
| Last Update Date | 10/03/2014 |
| Medicare PECOS PAC ID | 9133444961 |
|---|---|
| Medicare Enrollment ID | O20150218002399 |
News Archive
H. Julia Hannay, the John and Rebecca Moores Professor of Psychology at the University of Houston (UH), received the Lifetime Distinguished Career Award from the International Neuropsychological Society (INS) at its 41st annual meeting in Waikoloa, Hawaii. The award recognizes her contributions to the field of neuropsychology.
Surgeons treating patients with degenerative disc disease may now use a new stand-alone intervertebral body fusion device recently cleared by the Food and Drug Administration. Manufactured by Binder Biomedical Inc., the device presents a complete anterior lumbar fixation system with a simple, one-step locking mechanism.
In a new development a 12-member US panel is debating over the issue of menthol cigarettes being more addictive. If the results go against the cigarettes Australia too will have to ban the sale of such cigarettes. This would mean a significant loss to Alpine cigarettes and imported brands such as Kool, Virginia Slims and Salem.
ImmunoCellular Therapeutics, a clinical-stage biotechnology company focused on developing new immune-based products to treat cancer, today announced it has entered into an exclusive licensing agreement with Targepeutics, Inc. for ImmunoCellular's acquisition of Targepeutics' worldwide intellectual property rights surrounding the IL-13 receptor, alpha 2.
› Verified 5 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073916193 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RG0300X | Internal Medicine - Geriatric Medicine | A99416 (California) | Primary |
| Provider Name | Ehsan Ali |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1548451297 PECOS PAC ID: 7012086374 Enrollment ID: I20081118000231 |
News Archive
H. Julia Hannay, the John and Rebecca Moores Professor of Psychology at the University of Houston (UH), received the Lifetime Distinguished Career Award from the International Neuropsychological Society (INS) at its 41st annual meeting in Waikoloa, Hawaii. The award recognizes her contributions to the field of neuropsychology.
Surgeons treating patients with degenerative disc disease may now use a new stand-alone intervertebral body fusion device recently cleared by the Food and Drug Administration. Manufactured by Binder Biomedical Inc., the device presents a complete anterior lumbar fixation system with a simple, one-step locking mechanism.
In a new development a 12-member US panel is debating over the issue of menthol cigarettes being more addictive. If the results go against the cigarettes Australia too will have to ban the sale of such cigarettes. This would mean a significant loss to Alpine cigarettes and imported brands such as Kool, Virginia Slims and Salem.
ImmunoCellular Therapeutics, a clinical-stage biotechnology company focused on developing new immune-based products to treat cancer, today announced it has entered into an exclusive licensing agreement with Targepeutics, Inc. for ImmunoCellular's acquisition of Targepeutics' worldwide intellectual property rights surrounding the IL-13 receptor, alpha 2.
› Verified 5 days ago
| Provider Name | Simona Davoudpour |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1265688311 PECOS PAC ID: 9830230259 Enrollment ID: I20100107000565 |
News Archive
H. Julia Hannay, the John and Rebecca Moores Professor of Psychology at the University of Houston (UH), received the Lifetime Distinguished Career Award from the International Neuropsychological Society (INS) at its 41st annual meeting in Waikoloa, Hawaii. The award recognizes her contributions to the field of neuropsychology.
Surgeons treating patients with degenerative disc disease may now use a new stand-alone intervertebral body fusion device recently cleared by the Food and Drug Administration. Manufactured by Binder Biomedical Inc., the device presents a complete anterior lumbar fixation system with a simple, one-step locking mechanism.
In a new development a 12-member US panel is debating over the issue of menthol cigarettes being more addictive. If the results go against the cigarettes Australia too will have to ban the sale of such cigarettes. This would mean a significant loss to Alpine cigarettes and imported brands such as Kool, Virginia Slims and Salem.
ImmunoCellular Therapeutics, a clinical-stage biotechnology company focused on developing new immune-based products to treat cancer, today announced it has entered into an exclusive licensing agreement with Targepeutics, Inc. for ImmunoCellular's acquisition of Targepeutics' worldwide intellectual property rights surrounding the IL-13 receptor, alpha 2.
› Verified 5 days ago
| Provider Name | Linda Barkodar |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1124288147 PECOS PAC ID: 6406040443 Enrollment ID: I20101103000664 |
News Archive
H. Julia Hannay, the John and Rebecca Moores Professor of Psychology at the University of Houston (UH), received the Lifetime Distinguished Career Award from the International Neuropsychological Society (INS) at its 41st annual meeting in Waikoloa, Hawaii. The award recognizes her contributions to the field of neuropsychology.
Surgeons treating patients with degenerative disc disease may now use a new stand-alone intervertebral body fusion device recently cleared by the Food and Drug Administration. Manufactured by Binder Biomedical Inc., the device presents a complete anterior lumbar fixation system with a simple, one-step locking mechanism.
In a new development a 12-member US panel is debating over the issue of menthol cigarettes being more addictive. If the results go against the cigarettes Australia too will have to ban the sale of such cigarettes. This would mean a significant loss to Alpine cigarettes and imported brands such as Kool, Virginia Slims and Salem.
ImmunoCellular Therapeutics, a clinical-stage biotechnology company focused on developing new immune-based products to treat cancer, today announced it has entered into an exclusive licensing agreement with Targepeutics, Inc. for ImmunoCellular's acquisition of Targepeutics' worldwide intellectual property rights surrounding the IL-13 receptor, alpha 2.
› Verified 5 days ago
| Provider Name | Daniel Benhuri |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1003304189 PECOS PAC ID: 1254678907 Enrollment ID: I20230106001807 |
News Archive
H. Julia Hannay, the John and Rebecca Moores Professor of Psychology at the University of Houston (UH), received the Lifetime Distinguished Career Award from the International Neuropsychological Society (INS) at its 41st annual meeting in Waikoloa, Hawaii. The award recognizes her contributions to the field of neuropsychology.
Surgeons treating patients with degenerative disc disease may now use a new stand-alone intervertebral body fusion device recently cleared by the Food and Drug Administration. Manufactured by Binder Biomedical Inc., the device presents a complete anterior lumbar fixation system with a simple, one-step locking mechanism.
In a new development a 12-member US panel is debating over the issue of menthol cigarettes being more addictive. If the results go against the cigarettes Australia too will have to ban the sale of such cigarettes. This would mean a significant loss to Alpine cigarettes and imported brands such as Kool, Virginia Slims and Salem.
ImmunoCellular Therapeutics, a clinical-stage biotechnology company focused on developing new immune-based products to treat cancer, today announced it has entered into an exclusive licensing agreement with Targepeutics, Inc. for ImmunoCellular's acquisition of Targepeutics' worldwide intellectual property rights surrounding the IL-13 receptor, alpha 2.
› Verified 5 days ago
News Archive
H. Julia Hannay, the John and Rebecca Moores Professor of Psychology at the University of Houston (UH), received the Lifetime Distinguished Career Award from the International Neuropsychological Society (INS) at its 41st annual meeting in Waikoloa, Hawaii. The award recognizes her contributions to the field of neuropsychology.
Surgeons treating patients with degenerative disc disease may now use a new stand-alone intervertebral body fusion device recently cleared by the Food and Drug Administration. Manufactured by Binder Biomedical Inc., the device presents a complete anterior lumbar fixation system with a simple, one-step locking mechanism.
In a new development a 12-member US panel is debating over the issue of menthol cigarettes being more addictive. If the results go against the cigarettes Australia too will have to ban the sale of such cigarettes. This would mean a significant loss to Alpine cigarettes and imported brands such as Kool, Virginia Slims and Salem.
ImmunoCellular Therapeutics, a clinical-stage biotechnology company focused on developing new immune-based products to treat cancer, today announced it has entered into an exclusive licensing agreement with Targepeutics, Inc. for ImmunoCellular's acquisition of Targepeutics' worldwide intellectual property rights surrounding the IL-13 receptor, alpha 2.
› Verified 5 days ago
Treatmedngo Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 8950 W Olympic Blvd Ste 103&104, Beverly Hills, CA 90211 Phone: 310-274-8080 | |
Refael Medical, Inc. Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 8200 Wilshire Blvd, Beverly Hills, CA 90211 Phone: 310-879-7167 Fax: 310-933-5688 | |
Michael D. Borookhim, M.d., Inc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 9301 Wilshire Blvd, Suite 602, Beverly Hills, CA 90210 Phone: 310-288-0881 | |
Ultrasound Specialists Llc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 9001 Wilshire Blvd, Suite 106, Beverly Hills, CA 90211 Phone: 310-273-8885 | |
Kaiser Permanente Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 204 S Arnaz Dr Apt 3, Beverly Hills, CA 90211 Phone: 213-215-5142 | |
Nancy P. Rahnama, M.d., A.p.c. Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 421 N Rodeo Dr, Penthouse Number 1, Beverly Hills, CA 90210 Phone: 310-299-7373 Fax: 310-432-6647 | |
Laurence Seigler, M.d. Pc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 435 N Bedford Dr, Suite 308, Beverly Hills, CA 90210 Phone: 310-274-6158 Fax: 310-274-5709 |